Skip to content

Author

N. Beckmann

We have 3 of 88 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer

Background. Patients with advanced non-small cell lung cancer (NSCLC) and high PD-L1 (>50%) expression show improved outcomes with immune checkpoint inhibitors compared to chemotherapy. We hypothesized that concurrent durvalumab and radiotherapy (RT) without concurrent chemotherapy would be safe and feasible in patient...

Steven H. Lin, S. L. Pugh, D. Del Valle et al. · 0 citations
#machine learning Preprint Sep 2026

VANDAM: Viewing a nucleotide sequence with DNA molecular priors

Contemporary Genomic Foundation Models (GFMs) rely on a DNA-as-a-string paradigm that employs masked token prediction objectives for pretraining. However, this abstraction does not explicitly model the biochemical, structural, and physical properties essential to biological function. Many molecular properties can be es...

Jeremy Levy, Ariel Larey, Yury Nahshan et al. · 0 citations
Open access Sep 2026

DNT: Diploid Genomic Foundation Model

A reference-aligned diploid encoding for single-nucleotide variants (SNVs) and short insertions and deletions (indels) and unphased and phase-retaining tokenizers that accept phased genotypes and convert them to single-sequence diploid representation are introduced.

Guy Leib, T. Zinger, Dan Ofer et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.